Cite
Takahara I, Akazawa Y, Tabuchi M, et al. Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One. 2020;15(7):e0235729doi: 10.1371/journal.pone.0235729.
Takahara, I., Akazawa, Y., Tabuchi, M., Matsuda, K., Miyaaki, H., Kido, Y., Kanda, Y., Taura, N., Ohnita, K., Takeshima, F., Sakai, Y., Eguchi, S., Nakashima, M., & Nakao, K. (2020). Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PloS one, 15(7), e0235729. https://doi.org/10.1371/journal.pone.0235729
Takahara, Ikuko, et al. "Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice." PloS one vol. 15,7 (2020): e0235729. doi: https://doi.org/10.1371/journal.pone.0235729
Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F, Sakai Y, Eguchi S, Nakashima M, Nakao K. Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One. 2020 Jul 01;15(7):e0235729. doi: 10.1371/journal.pone.0235729. eCollection 2020. PMID: 32609746; PMCID: PMC7329070.
Copy
Download .nbib